Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04034706 · ClinicalTrials.gov registry record

Transcriptional and Epigenetic Program of PCOS Women

A clinical trial of PCOS, sponsored by AdventHealth Translational Research Institute.

Active
Registry status
108
Enrollment target
1
Study location

NCT04034706 is a study of PCOS that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 108 participants, above the 70-participant average among 8 other PCOS trials with a reported enrollment target (54% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04034706, a study of PCOS, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.

ACTIVE NOT RECRUITING
Registry status
108 participants
Enrollment target
1
Study location

Study Summary

The main goal is to reveal differences in global gene expression in two different adipose tissue (AT) depots of females with and without polycystic ovary syndrome (PCOS) and how these are influenced by upstream epigenetic markers

Conditions Studied

Interventions

  • OTHER DEXA
  • OTHER Magnetic Resonance (MR) Assessment of the Abdomen
  • OTHER MR assessment of Whole Body Fat
  • PROCEDURE Adipose tissue biopsy
  • OTHER Oral glucose tolerance test

Study Locations (1)

Florida

  • AdventHealth Translational Research Institute - Orlando

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2020-01-31
Est. Completion 2025-12

What the Registry Record Tells You About NCT04034706

The ClinicalTrials.gov registry entry for NCT04034706 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 70-participant average among 8 other PCOS trials with a reported enrollment target (54% higher). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PCOS appearing as the primary indexed condition, and to 5 interventions - of which DEXA is the first listed.

NCT04034706 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04034706 about?

NCT04034706 is a clinical study titled "Transcriptional and Epigenetic Program of PCOS Women". The main goal is to reveal differences in global gene expression in two different adipose tissue (AT) depots of females with and without polycystic ovary syndrome (PCOS) and how these are influenced by upstream epigenetic markers

What is the current status of trial NCT04034706?

This trial is currently active not recruiting. The enrollment target is 108 participants. The study started on 2020-01-31. Estimated completion is 2025-12.

What conditions does trial NCT04034706 study?

This clinical trial studies the following conditions: PCOS.

What interventions are being tested in trial NCT04034706?

The interventions under investigation include: DEXA (OTHER), Magnetic Resonance (MR) Assessment of the Abdomen (OTHER), MR assessment of Whole Body Fat (OTHER), Adipose tissue biopsy (PROCEDURE), Oral glucose tolerance test (OTHER).

Who is sponsoring clinical trial NCT04034706?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04034706 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PCOS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.